---
layout: minimal-medicine
title: Atrasentan
---

# Atrasentan
### Generic Name
Atrasentan

### Usage
Atrasentan is primarily being developed as an oral treatment for diabetic nephropathies (kidney disease related to diabetes).  While it was also under investigation for certain cancers (specifically prostate cancer) in earlier phases of clinical trials, there haven't been any recent updates suggesting continued development in these areas.  Therefore, its current primary and most likely future use is focused solely on diabetic kidney disease.

### Dosage
Currently, there is no publicly available information regarding approved dosages of Atrasentan for diabetic nephropathy.  This is because the drug has not yet received regulatory approval for any indication. Any dosage information would need to come directly from clinical trial data, which is often not readily accessible to the public.  Future prescribing information, if and when Atrasentan gains approval, will specify dosages based on factors like age, weight, kidney function, and the severity of the diabetic nephropathy.  This information will likely be detailed in the official product monograph.

### Side Effects
Because Atrasentan is still under development and hasn't received regulatory approval, comprehensive information on side effects isn't publicly available.  However, based on the nature of the drug and its mechanism of action, potential side effects might include (but are not limited to):

* Headache
* Nausea
* Dizziness
* Elevated liver enzymes
* Swelling in the extremities
* Fatigue

It is crucial to remember that this is not an exhaustive list, and serious, albeit less common, side effects may occur.  **If you experience any adverse effects while participating in a clinical trial involving Atrasentan, immediately report them to your healthcare provider.**

### How it Works
Atrasentan works by selectively blocking the endothelin A receptor.  Endothelin is a potent vasoconstrictor (a substance that narrows blood vessels) and plays a role in several processes relevant to diabetic nephropathy, including inflammation, fibrosis (scarring), and cell proliferation (uncontrolled cell growth) within the kidneys.  By blocking the endothelin A receptor, Atrasentan inhibits the actions of endothelin, potentially slowing the progression of kidney damage in patients with diabetic nephropathy.  The precise mechanisms contributing to its therapeutic effect are still under investigation.

### Precautions
Since Atrasentan is not yet approved for market use, comprehensive precaution information is unavailable. However, based on its mechanism and potential side effects, it's likely that precautions will include:

* **Liver Function Monitoring:**  Atrasentan may affect liver function; regular monitoring might be necessary.
* **Kidney Function Monitoring:**  Since Atrasentan targets kidney disease, careful monitoring of kidney function is anticipated.
* **Drug Interactions:** The potential for interactions with other medications needs to be thoroughly investigated before approval.
* **Pregnancy and Breastfeeding:**  Use during pregnancy and breastfeeding would likely be discouraged until more safety data becomes available.
* **Elderly Patients:** Dosage adjustments may be required for older adults due to potential differences in drug metabolism and clearance.


### FAQs

**Q: Is Atrasentan currently available to buy?**
A: No, Atrasentan is not currently available for purchase as it has not yet received regulatory approval.


**Q: Where can I find more information about Atrasentan clinical trials?**
A: ClinicalTrials.gov is a good resource to search for ongoing or completed clinical trials.  However, access to detailed data from specific trials is often restricted.

**Q:  If Atrasentan is approved, how will it be stored?**
A: This information will be provided in the product monograph when and if the drug receives regulatory approval.  However, it's likely to involve storage at room temperature and protection from light and moisture.


**Disclaimer:** This information is intended for educational purposes only and should not be considered medical advice. Always consult with a healthcare professional for any health concerns or before making any decisions related to your health or treatment.  The information provided here is based on currently available data, and itâ€™s important to remember that ongoing research may lead to updates in our understanding of Atrasentan.
